SS Innovations International, Inc. (SSII) stock
SSIINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 8/3063% below fair value
$1.33−0.02 (-1.48%)
Close on Nov 17, 2026Market cap $266.51MP/E –Yield –
SS Innovations International r&d expenses
Research and development expenses are spending on new products and technology.
SS Innovations International's R&D Expenses for the twelve months ending Jun 30, 2026 was $5.57M, up 105.2% year over year. For fiscal 2025 it was $3.69M, up 47.9% from the year before. The highest annual figure on record is $3.69M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.69M | +47.9% |
| FY2024 | Dec 31, 2024 | $2.49M | +135.4% |
| FY2023 | Dec 31, 2023 | $1.06M | +7.2% |
| FY2022 | Dec 31, 2022 | $987.44K | +98644.3% |
| FY2021 | Dec 31, 2021 | $1.00K | -66.7% |
| FY2020 | Dec 31, 2020 | $3.00K | -95.1% |
| FY2019 | Dec 31, 2019 | $60.87K | +124.4% |
| FY2018 | Dec 31, 2018 | $27.13K | -61.9% |
| FY2017 | Dec 31, 2017 | $71.17K | -44.2% |
| FY2016 | Dec 31, 2016 | $127.58K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.40M | +380.5% |
| Q1 FY2026 | Mar 31, 2026 | $995.44K | -1.5% |
| Q4 FY2025 | Dec 31, 2025 | $1.39M | +82.5% |
| Q3 FY2025 | Sep 30, 2025 | $786.32K | +77.6% |
| Q2 FY2025 | Jun 30, 2025 | $498.60K | -34.3% |
| Q1 FY2025 | Mar 31, 2025 | $1.01M | +91.3% |
| Q4 FY2024 | Dec 31, 2024 | $761.94K | +173.9% |
| Q3 FY2024 | Sep 30, 2024 | $442.84K | +51.7% |
| Q2 FY2024 | Jun 30, 2024 | $759.00K | +208.0% |
| Q1 FY2024 | Mar 31, 2024 | $527.99K | +118.1% |
| Q4 FY2023 | Dec 31, 2023 | $278.20K | +796.3% |
| Q3 FY2023 | Sep 30, 2023 | $291.91K | +86.5% |
| Q2 FY2023 | Jun 30, 2023 | $246.43K | – |
| Q1 FY2023 | Mar 31, 2023 | $242.13K | – |
| Q4 FY2022 | Dec 31, 2022 | $31.04K | +3003.7% |
| Q3 FY2022 | Sep 30, 2022 | $156.49K | – |
| Q4 FY2021 | Dec 31, 2021 | $0 | – |
| Q3 FY2021 | Sep 30, 2021 | $0 | -100.0% |
| Q4 FY2020 | Dec 31, 2020 | $1.00K | -77.8% |
| Q3 FY2020 | Sep 30, 2020 | $0 | -100.0% |
| Q2 FY2020 | Jun 30, 2020 | $0 | -100.0% |
| Q1 FY2020 | Mar 31, 2020 | $2.00K | -91.7% |
| Q4 FY2019 | Dec 31, 2019 | $4.50K | -45.0% |
| Q3 FY2019 | Sep 30, 2019 | $4.50K | +69.2% |
| Q2 FY2019 | Jun 30, 2019 | $27.81K | +99.2% |
| Q1 FY2019 | Mar 31, 2019 | $24.06K | -48.3% |
| Q4 FY2018 | Dec 31, 2018 | $8.18K | -82.2% |
| Q3 FY2018 | Sep 30, 2018 | $2.66K | -95.1% |
| Q4 FY2017 | Dec 31, 2017 | $13.96K | -48.7% |
| Q1 FY2017 | Mar 31, 2017 | $46.52K | – |
| Q4 FY2016 | Dec 31, 2016 | $45.92K | – |
| Q3 FY2016 | Sep 30, 2016 | $54.44K | – |
| Q2 FY2016 | Jun 30, 2016 | $27.22K | – |
See a number that looks wrong?